396652-38-3

Basic information

• Product Name: Methyl 1-methyl-2-oxo-2,3-dihydro-1H-1,3-benzimidazole-5-carboxylate
• Synonyms: Methyl 1-methyl-2-oxo-2,3-dihydro-1H-1,3-benzimidazole-5-carboxylate
• CAS NO: 396652-38-3
• Molecular Formula: C10H10N2O3
• Molecular Weight: 206.198
• Mol File: 396652-38-3.mol
• Article Data: 8

Chemical Properties

• Melting Point: 253-255°
• Appearance: /
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: Methyl 1-methyl-2-oxo-2,3-dihydro-1H-1,3-benzimidazole-5-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: Methyl 1-methyl-2-oxo-2,3-dihydro-1H-1,3-benzimidazole-5-carboxylate(396652-38-3)
• EPA Substance Registry System: Methyl 1-methyl-2-oxo-2,3-dihydro-1H-1,3-benzimidazole-5-carboxylate(396652-38-3)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 396652-38-3(Hazardous Substances Data)

Upstream product

• 66315-16-0 methyl 3-amino-4-(methylamino)benzoate 
• 530-62-1 1,1'-carbonyldiimidazole 
• 14719-83-6 methyl 3-nitro-4-chlorobenzoate 
• 36242-50-9 4-methylamino-3-nitro-benzoic acid methyl ester 
• 329-59-9 4-fluoro-3-nitro-benzoic acid methyl ester 

Downstream Products

• 64826-45-5 1,3-dimethyl-2-oxo-2,3-dihydro-1H-benzo[d]imidazole-5-carboxylic acid 

Relevant articles and documents

Iron-Catalyzed Intramolecular C—H Amidation of N-Benzoyloxyureas

A redox-neutral Fe-catalyzed intramolecular C—H amidation of N-benzoyloxyureas is described. This methodology employs a simple iron complex in situ generated from Fe(OTf)2 and bipyridine as the catalyst and N-benzoyloxyureas as the nitrene prec

KINASE INHIBITOR COMPOUNDS AND COMPOSITIONS AND METHODS OF USE

The present invention is directed to kinase inhibitor compounds having the following structure: or a stereoisomer, pharmaceuticallyacceptable salt, oxide, or solvate thereof, where R1, R2, X, n, R3, Y, Z, R4, R

BICYCLIC HYDROXAMIC ACIDS USEFUL AS INHIBITORS OF MAMMALIAN HISTONE DEACETYLASE ACTIVITY

A compound of formula (Ia) or (Ib) or a pharmaceutically acceptable salt thereof. The compound is an inhibitor of a histone deacetylase, and as such is useful in terepy, e.g. in the treatment of autoimmune disorders, mental disorders, neurodegenerative disorders, and hyperproliferative disorders.